| scholarly article | Q13442814 |
| P2093 | author name string | S. T. Crooke | |
| V. Mohan | |||
| W. F. Lima | |||
| P2860 | cites work | A new principle of RNA folding based on pseudoknotting | Q24624606 |
| Structure of ribonuclease H phased at 2 A resolution by MAD analysis of the selenomethionyl protein | Q27670506 | ||
| The structure of an RNA pseudoknot that causes efficient frameshifting in mouse mammary tumor virus | Q27730190 | ||
| Three-dimensional structure of ribonuclease H from E. coli | Q34566873 | ||
| Observation of the A-DNA to B-DNA transition during unrestrained molecular dynamics in aqueous solution | Q36804416 | ||
| How does RNase H recognize a DNA.RNA hybrid? | Q37652341 | ||
| Site-specific excision from RNA by RNase H and mixed-phosphate-backbone oligodeoxynucleotides | Q37696968 | ||
| Uniformly modified 2'-deoxy-2'-fluoro phosphorothioate oligonucleotides as nuclease-resistant antisense compounds with high affinity and specificity for RNA targets | Q38320249 | ||
| Pseudo--half-knot formation with RNA | Q38326790 | ||
| Binding affinity and specificity of Escherichia coli RNase H1: impact on the kinetics of catalysis of antisense oligonucleotide-RNA hybrids | Q38349308 | ||
| Enhanced activity of an antisense oligonucleotide targeting murine protein kinase C-alpha by the incorporation of 2'-O-propyl modifications | Q39715452 | ||
| Targeted degradation of mRNA inXenopusoocytes and embryos directed by modified oligonucleotides: studies of An2 and cyclin in embryogenesis | Q40522436 | ||
| Progress in antisense therapeutics | Q41106618 | ||
| Nuclease resistance and antisense activity of modified oligonucleotides targeted to Ha-ras | Q41192006 | ||
| Partial protection of oncogene, anti-sense oligodeoxynucleotides against serum nuclease degradation using terminal methylphosphonate groups | Q41760845 | ||
| Kinetic characteristics of Escherichia coli RNase H1: cleavage of various antisense oligonucleotide-RNA duplexes | Q41908017 | ||
| A pseudoknotted RNA oligonucleotide | Q44469085 | ||
| Implication of RNA structure on antisense oligonucleotide hybridization kinetics | Q45059437 | ||
| Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase | Q46110468 | ||
| RNA pseudoknots. Stability and loop size requirements | Q46984193 | ||
| Ribonuclease H. An Enzyme Degrading the RNA Moiety of DNA-RNA Hybrids | Q55980195 | ||
| Sequence-dependent hydrolysis of RNA using modified oligonucleotide splints and RNase H | Q68993821 | ||
| P433 | issue | 29 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Escherichia coli | Q25419 |
| P1104 | number of pages | 9 | |
| P304 | page(s) | 18191-18199 | |
| P577 | publication date | 1997-07-01 | |
| 1997-07-18 | |||
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | The influence of antisense oligonucleotide-induced RNA structure on Escherichia coli RNase H1 activity | |
| The Influence of Antisense Oligonucleotide-induced RNA Structure on Escherichia coli RNase H1 Activity | |||
| P478 | volume | 272 |
| Q33916133 | 2'-carbohydrate modifications in antisense oligonucleotide therapy: importance of conformation, configuration and conjugation |
| Q34268755 | A critical survey of the structure-function of the antisense oligo/RNA heteroduplex as substrate for RNase H. |
| Q42270700 | A novel 4-arm DNA/RNA Nanoconstruct triggering Rapid Apoptosis of Triple Negative Breast Cancer Cells within 24 hours |
| Q28542911 | Allele-specific suppression of mutant huntingtin using antisense oligonucleotides: providing a therapeutic option for all Huntington disease patients |
| Q30960956 | Biochemical properties of phosphonoacetate and thiophosphonoacetate oligodeoxyribonucleotides |
| Q38342120 | Cleavage of single strand RNA adjacent to RNA-DNA duplex regions by Escherichia coli RNase H1. |
| Q38066620 | Clinical pharmacokinetics of second generation antisense oligonucleotides |
| Q36580411 | Crystallization and preliminary X-ray analysis of Escherichia coli RNase HI-dsRNA complexes |
| Q24608092 | Crystallographic studies of chemically modified nucleic acids: a backward glance |
| Q30672419 | DNA aptamers selected against the HIV-1 trans-activation-responsive RNA element form RNA-DNA kissing complexes |
| Q33763978 | DNAzyme-mediated recovery of small recombinant RNAs from a 5S rRNA-derived chimera expressed in Escherichia coli |
| Q34298362 | Determination of the role of the human RNase H1 in the pharmacology of DNA-like antisense drugs |
| Q38287887 | Fatty Acid-Modified Gapmer Antisense Oligonucleotide and Serum Albumin Constructs for Pharmacokinetic Modulation. |
| Q27651744 | Insights into RNA/DNA hybrid recognition and processing by RNase H from the crystal structure of a non-specific enzyme-dsDNA complex |
| Q74109346 | Mapping of RNA accessible sites for antisense experiments with oligonucleotide libraries |
| Q30850742 | Mapping of accessible sites for oligonucleotide hybridization on hepatitis delta virus ribozymes |
| Q33936673 | Post-transcriptional gene-silencing: RNAs on the attack or on the defense? |
| Q34293601 | Potential roles of antisense technology in cancer chemotherapy |
| Q33792920 | Progress in antisense technology: the end of the beginning |
| Q33874988 | Properties of cloned and expressed human RNase H1. |
| Q39516215 | RNase H mediated cleavage of RNA by cyclohexene nucleic acid (CeNA). |
| Q34646173 | The effect of structure in a long target RNA on ribozyme cleavage efficiency |
| Q77376171 | Towards the structure-based design of oligonucleotide therapeutics |
Search more.